WHO suggestions demand manufacturers to employ a continuous possibility administration system for sterility test isolators, together with normal risk assessments and the development of possibility-primarily based control tactics. Manufacturers wanting to put into practice these procedures will have to give robust validation info to demonstrate their equivalence to pharmacopoeial waiting for link from Forum Profiles (11)